| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.093 | 0.07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.09 | 0.07 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |